Lin Shen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 64

Top Venues

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

This page only lists publications with an associated author ORCID identifier.

Publications

Yilin Li, Lei Jiang, Yang Chen, Yanyan Li, Jiajia Yuan, Jialin Lu, Zizhen Zhang, Shengde Liu, Xujiao Feng, Jiaxin Xiong, Yan Jiang, Xiaotian Zhang, Jian Li, Lin Shen
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Xiang-Yu Gao, Ke Ji, Yongning Jia, Fei Shan, Ye Chen, Nong Xu, Ziyu Jia, Tian-Shu Liu, Nong Yang, Haijun Zhong, Changzheng Li, Zengqing Guo, Qingxia Fan, Xiaoyan Lin, Yan Zhang, Hui Ren, Hongxia Yang, Zhifang Yao, Wei Liu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Lin Shen, Zi-Yu Li, Jia Fu Ji
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial. Nature medicine (2024)
Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, Xicheng Wang, Panpan Zhang, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Zhihao Lu, Ming Lu, Yanshuo Cao, Jiajia Yuan, Yakun Wang, Zhenghang Wang, Ran Xue, Xiaohui Peng, Yumeng Wang, Daijing Yuan, Jian Li, Xiaotian Zhang, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nature medicine 30 (8) (2024)
Yilin Li, Lei Jiang, Yang Chen, Yanyan Li, Jiajia Yuan, Jialin Lu, Zizhen Zhang, Shengde Liu, Xujiao Feng, Jiaxin Xiong, Yan Jiang, Xiaotian Zhang, Jian Li, Lin Shen
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Yilin Li, Lei Jiang, Yang Chen, Yanyan Li, Jiajia Yuan, Jialin Lu, Zizhen Zhang, Shengde Liu, Xujiao Feng, Jiaxin Xiong, Yan Jiang, Xiaotian Zhang, Jian Li, Lin Shen
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Yanni Wang, Chang Liu, Huan Chen, Xi Jiao, Yujiao Wang, Yanshuo Cao, Jian Li, Xiaotian Zhang, Yu Sun, Na Zhuo, Fengxiao Dong, Mengting Gao, Fengyuan Wang, Liyuan Dong, Jifang Gong, Tianqi Sun, Wei Zhu, Henghui Zhang, Lin Shen, Zhihao Lu
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Zifan Chen, Yang Chen, Yu Sun, Lei Tang, Li Zhang, Yajie Hu, Meng He, Zhiwei Li, Siyuan Cheng, Jiajia Yuan, Zhenghang Wang, Yakun Wang, Jie Zhao, Jifang Gong, Liying Zhao, Baoshan Cao, Guoxin Li, Xiaotian Zhang, Bin Dong, Lin Shen
Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data. Signal transduction and targeted therapy 9 (1) (2024)
Yanni Wang, Chang Liu, Huan Chen, Xi Jiao, Yujiao Wang, Yanshuo Cao, Jian Li, Xiaotian Zhang, Yu Sun, Na Zhuo, Fengxiao Dong, Mengting Gao, Fengyuan Wang, Liyuan Dong, Jifang Gong, Tianqi Sun, Wei Zhu, Henghui Zhang, Lin Shen, Zhihao Lu
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Izuma Nakayama, Changsong Qi, Yang Chen, Yoshiaki Nakamura, Lin Shen, Kohei Shitara
Claudin 18.2 as a novel therapeutic target. Nature reviews. Clinical oncology (2024)
Yanni Wang, Chang Liu, Huan Chen, Xi Jiao, Yujiao Wang, Yanshuo Cao, Jian Li, Xiaotian Zhang, Yu Sun, Na Zhuo, Fengxiao Dong, Mengting Gao, Fengyuan Wang, Liyuan Dong, Jifang Gong, Tianqi Sun, Wei Zhu, Henghui Zhang, Lin Shen, Zhihao Lu
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Mengting Gao, Xueying Wu, Xi Jiao, Ying Hu, Yanni Wang, Na Zhuo, Fengxiao Dong, Yujiao Wang, Fengyuan Wang, Yanshuo Cao, Chang Liu, Jian Li, Lin Shen, Henghui Zhang, Zhihao Lu
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for immunotherapy of cancer 12 (2) (2024)
Yilin Li, Lei Jiang, Yang Chen, Yanyan Li, Jiajia Yuan, Jialin Lu, Zizhen Zhang, Shengde Liu, Xujiao Feng, Jiaxin Xiong, Yan Jiang, Xiaotian Zhang, Jian Li, Lin Shen
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Mengting Gao, Xueying Wu, Xi Jiao, Ying Hu, Yanni Wang, Na Zhuo, Fengxiao Dong, Yujiao Wang, Fengyuan Wang, Yanshuo Cao, Chang Liu, Jian Li, Lin Shen, Henghui Zhang, Zhihao Lu
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for immunotherapy of cancer 12 (2) (2024)
Mengting Gao, Xueying Wu, Xi Jiao, Ying Hu, Yanni Wang, Na Zhuo, Fengxiao Dong, Yujiao Wang, Fengyuan Wang, Yanshuo Cao, Chang Liu, Jian Li, Lin Shen, Henghui Zhang, Zhihao Lu
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for immunotherapy of cancer 12 (2) (2024)
Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, Xicheng Wang, Panpan Zhang, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Zhihao Lu, Ming Lu, Yanshuo Cao, Jiajia Yuan, Yakun Wang, Zhenghang Wang, Ran Xue, Xiaohui Peng, Yumeng Wang, Daijing Yuan, Jian Li, Xiaotian Zhang, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nature medicine (2024)
Mengting Gao, Xueying Wu, Xi Jiao, Ying Hu, Yanni Wang, Na Zhuo, Fengxiao Dong, Yujiao Wang, Fengyuan Wang, Yanshuo Cao, Chang Liu, Jian Li, Lin Shen, Henghui Zhang, Zhihao Lu
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for immunotherapy of cancer 12 (2) (2024)
Xiang-Yu Gao, Ke Ji, Yongning Jia, Fei Shan, Ye Chen, Nong Xu, Ziyu Jia, Tian-Shu Liu, Nong Yang, Haijun Zhong, Changzheng Li, Zengqing Guo, Qingxia Fan, Xiaoyan Lin, Yan Zhang, Hui Ren, Hongxia Yang, Zhifang Yao, Wei Liu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Lin Shen, Zi-Yu Li, Jia Fu Ji
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial. Nature medicine 30 (7) (2024)
Zifan Chen, Yang Chen, Yu Sun, Lei Tang, Li Zhang, Yajie Hu, Meng He, Zhiwei Li, Siyuan Cheng, Jiajia Yuan, Zhenghang Wang, Yakun Wang, Jie Zhao, Jifang Gong, Liying Zhao, Baoshan Cao, Guoxin Li, Xiaotian Zhang, Bin Dong, Lin Shen
Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data. Signal transduction and targeted therapy 9 (1) (2024)
Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, Xicheng Wang, Panpan Zhang, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Zhihao Lu, Ming Lu, Yanshuo Cao, Jiajia Yuan, Yakun Wang, Zhenghang Wang, Ran Xue, Xiaohui Peng, Yumeng Wang, Daijing Yuan, Jian Li, Xiaotian Zhang, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nature medicine 30 (8) (2024)
Zifan Chen, Yang Chen, Yu Sun, Lei Tang, Li Zhang, Yajie Hu, Meng He, Zhiwei Li, Siyuan Cheng, Jiajia Yuan, Zhenghang Wang, Yakun Wang, Jie Zhao, Jifang Gong, Liying Zhao, Baoshan Cao, Guoxin Li, Xiaotian Zhang, Bin Dong, Lin Shen
Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data. Signal transduction and targeted therapy 9 (1) (2024)
Izuma Nakayama, Changsong Qi, Yang Chen, Yoshiaki Nakamura, Lin Shen, Kohei Shitara
Claudin 18.2 as a novel therapeutic target. Nature reviews. Clinical oncology 21 (5) (2024)
Yilin Li, Lei Jiang, Yang Chen, Yanyan Li, Jiajia Yuan, Jialin Lu, Zizhen Zhang, Shengde Liu, Xujiao Feng, Jiaxin Xiong, Yan Jiang, Xiaotian Zhang, Jian Li, Lin Shen
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Yilin Li, Lei Jiang, Yang Chen, Yanyan Li, Jiajia Yuan, Jialin Lu, Zizhen Zhang, Shengde Liu, Xujiao Feng, Jiaxin Xiong, Yan Jiang, Xiaotian Zhang, Jian Li, Lin Shen
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Xiang-Yu Gao, Ke Ji, Yongning Jia, Fei Shan, Ye Chen, Nong Xu, Ziyu Jia, Tian-Shu Liu, Nong Yang, Haijun Zhong, Changzheng Li, Zengqing Guo, Qingxia Fan, Xiaoyan Lin, Yan Zhang, Hui Ren, Hongxia Yang, Zhifang Yao, Wei Liu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Lin Shen, Zi-Yu Li, Jia Fu Ji
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial. Nature medicine 30 (7) (2024)
Izuma Nakayama, Changsong Qi, Yang Chen, Yoshiaki Nakamura, Lin Shen, Kohei Shitara
Claudin 18.2 as a novel therapeutic target. Nature reviews. Clinical oncology 21 (5) (2024)
Dan Liu, Furong Kou, Jifang Gong, Zhiqiang Wang, Xiaotian Zhang, Jian Li, Yan Li, Jie Li, Jun Zhou, Ming Lu, Xicheng Wang, Zhihao Lu, Yanshuo Cao, Jianjun Zou, Xiaoyu Zhu, Ruihua Xu, Lin Shen
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study. Cancer medicine (2023)
Hongyan Yin, Qian Yao, Yi Xie, Dongfeng Niu, Wenya Jiang, Huiying Cao, Xujiao Feng, Yanyan Li, Yilin Li, Xiaotian Zhang, Lin Shen, Yang Chen
Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma. Cancer medicine (2023)
Weicai Huang, Wenjun Xiong, Tang Lei, Chuanli Chen, Qingyu Yuan, Cheng Zhang, Kangneng Zhou, Zepang Sun, Taojun Zhang, Zhen Han, Hao Feng, Xiaokun Liang, Yonghong Zhong, Haijun Deng, Lequan Yu, Yikai Xu, Wei Wang, Lin Shen, Guoxin Li, Yuming Jiang
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study. Journal for immunotherapy of cancer 11 (11) (2023)
Weicai Huang, Wenjun Xiong, Tang Lei, Chuanli Chen, Qingyu Yuan, Cheng Zhang, Kangneng Zhou, Zepang Sun, Taojun Zhang, Zhen Han, Hao Feng, Xiaokun Liang, Yonghong Zhong, Haijun Deng, Lequan Yu, Yikai Xu, Wei Wang, Lin Shen, Guoxin Li, Yuming Jiang
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study. Journal for immunotherapy of cancer 11 (11) (2023)
Dan Liu, Furong Kou, Jifang Gong, Zhiqiang Wang, Xiaotian Zhang, Jian Li, Yan Li, Jie Li, Jun Zhou, Ming Lu, Xicheng Wang, Zhihao Lu, Yanshuo Cao, Jianjun Zou, Xiaoyu Zhu, Ruihua Xu, Lin Shen
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study. Cancer medicine (2023)
Weicai Huang, Wenjun Xiong, Tang Lei, Chuanli Chen, Qingyu Yuan, Cheng Zhang, Kangneng Zhou, Zepang Sun, Taojun Zhang, Zhen Han, Hao Feng, Xiaokun Liang, Yonghong Zhong, Haijun Deng, Lequan Yu, Yikai Xu, Wei Wang, Lin Shen, Guoxin Li, Yuming Jiang
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study. Journal for immunotherapy of cancer 11 (11) (2023)
Wenhao Shi, Yushen Wang, Chen Xu, Yan Li, Sai Ge, Bin Bai, Kecheng Zhang, Yunzhi Wang, Nairen Zheng, Juan Wang, Shiqi Wang, Gang Ji, Jipeng Li, Yongzhan Nie, Wenquan Liang, Xiaosong Wu, Jianxin Cui, Yi Wang, Lin Chen, Qingchuan Zhao, Lin Shen, Fuchu He, Jun Qin, Chen Ding
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. Nature communications 14 (1) (2023)
Wenhao Shi, Yushen Wang, Chen Xu, Yan Li, Sai Ge, Bin Bai, Kecheng Zhang, Yunzhi Wang, Nairen Zheng, Juan Wang, Shiqi Wang, Gang Ji, Jipeng Li, Yongzhan Nie, Wenquan Liang, Xiaosong Wu, Jianxin Cui, Yi Wang, Lin Chen, Qingchuan Zhao, Lin Shen, Fuchu He, Jun Qin, Chen Ding
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. Nature communications 14 (1) (2023)
Weicai Huang, Wenjun Xiong, Tang Lei, Chuanli Chen, Qingyu Yuan, Cheng Zhang, Kangneng Zhou, Zepang Sun, Taojun Zhang, Zhen Han, Hao Feng, Xiaokun Liang, Yonghong Zhong, Haijun Deng, Lequan Yu, Yikai Xu, Wei Wang, Lin Shen, Guoxin Li, Yuming Jiang
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study. Journal for immunotherapy of cancer 11 (11) (2023)
Lei Jiang, Xingwang Zhao, Yilin Li, Yajie Hu, Yu Sun, Shengde Liu, Zizhen Zhang, Yanyan Li, Xujiao Feng, Jiajia Yuan, Jian Li, Xiaotian Zhang, Yang Chen, Lin Shen
The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer. IUBMB life 76 (7) (2023)
Dan Liu, Furong Kou, Jifang Gong, Zhiqiang Wang, Xiaotian Zhang, Jian Li, Yan Li, Jie Li, Jun Zhou, Ming Lu, Xicheng Wang, Zhihao Lu, Yanshuo Cao, Jianjun Zou, Xiaoyu Zhu, Ruihua Xu, Lin Shen
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study. Cancer medicine (2023)
Meng He, Zi-Fan Chen, Li Zhang, Xiangyu Gao, Xiaoyi Chong, Hao-Shen Li, Lin Shen, Jia Fu Ji, Xiaotian Zhang, Bin Dong, Zi-Yu Li, Tang Lei
Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade. Journal for immunotherapy of cancer 11 (6) (2023)
Wenhao Shi, Yushen Wang, Chen Xu, Yan Li, Sai Ge, Bin Bai, Kecheng Zhang, Yunzhi Wang, Nairen Zheng, Juan Wang, Shiqi Wang, Gang Ji, Jipeng Li, Yongzhan Nie, Wenquan Liang, Xiaosong Wu, Jianxin Cui, Yi Wang, Lin Chen, Qingchuan Zhao, Lin Shen, Fuchu He, Jun Qin, Chen Ding
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. Nature communications 14 (1) (2023)
Zhihao Lu, Yang Chen, Dan Liu, Xi Jiao, Chang Liu, Yakun Wang, Zizhen Zhang, Keren Jia, Jifang Gong, Zhimin Yang, Lin Shen
The landscape of cancer research and cancer care in China. Nature medicine 29 (12) (2023)
Lei Jiang, Xingwang Zhao, Yilin Li, Yajie Hu, Yu Sun, Shengde Liu, Zizhen Zhang, Yanyan Li, Xujiao Feng, Jiajia Yuan, Jian Li, Xiaotian Zhang, Yang Chen, Lin Shen
The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer. IUBMB life (2023)
Wenhao Shi, Yushen Wang, Chen Xu, Yan Li, Sai Ge, Bin Bai, Kecheng Zhang, Yunzhi Wang, Nairen Zheng, Juan Wang, Shiqi Wang, Gang Ji, Jipeng Li, Yongzhan Nie, Wenquan Liang, Xiaosong Wu, Jianxin Cui, Yi Wang, Lin Chen, Qingchuan Zhao, Lin Shen, Fuchu He, Jun Qin, Chen Ding
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. Nature communications 14 (1) (2023)
Dan Liu, Furong Kou, Jifang Gong, Zhiqiang Wang, Xiaotian Zhang, Jian Li, Yan Li, Jie Li, Jun Zhou, Ming Lu, Xicheng Wang, Zhihao Lu, Yanshuo Cao, Jianjun Zou, Xiaoyu Zhu, Ruihua Xu, Lin Shen
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study. Cancer medicine (2023)
Meng He, Zi-Fan Chen, Li Zhang, Xiangyu Gao, Xiaoyi Chong, Hao-Shen Li, Lin Shen, Jia Fu Ji, Xiaotian Zhang, Bin Dong, Zi-Yu Li, Tang Lei
Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade. Journal for immunotherapy of cancer 11 (6) (2023)
Zhenghang Wang, Qi Zhang, Changsong Qi, Yuezong Bai, Feilong Zhao, Hui Chen, Zhongwu Li, Xicheng Wang, Mifen Chen, Jifang Gong, Zhi Peng, Xiaotian Zhang, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Lin Shen, Jian Li
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer. Journal for immunotherapy of cancer 10 (6) (2022)
Jifang Gong, Junning Cao, Qingyuan Zhang, Nong Xu, Yanqiu Zhao, Baocai Xing, Zhanhui Miao, Yilong Wu, Hongming Pan, Quanli Gao, Xingya Li, Baorui Liu, Wei Li, Zhidong Pei, Hongqiang Xia, Qinzhou Qi, Hangjun Dai, Qingmei Shi, Jianxin Yang, Jin Li, Lin Shen
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial. Cancer immunology, immunotherapy : CII 71 (8) (2022)
Zhihao Lu, Junye Wang, Yongqian Shu, Lianke Liu, Li Kong, Lei Yang, Buhai Wang, Guogui Sun, Yinghua Ji, Guochun Cao, Hu Liu, Tongjian Cui, Na Li, Wensheng Qiu, Gaofeng Li, Xinfang Hou, Hui Luo, Liying Xue, Yanqiao Zhang, Wenbin Yue, Zheng Liu, Xiuwen Wang, Shegan Gao, Yueyin Pan, Marie-Pierre Galais, Aziz Zaanan, Zhuo Ma, Haoyu Li, Yan Wang, Lin Shen, null null
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial. BMJ (Clinical research ed.) 377 (2022)
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, double-blind, placebo-controlled phase 3 study of paclitaxel {plus minus} napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Yang Chen, Keren Jia, Yu Sun, Cheng Zhang, Yilin Li, Li Zhang, Zifan Chen, Jiangdong Zhang, Yajie Hu, Jiajia Yuan, Xingwang Zhao, Yanyan Li, Jifang Gong, Bin Dong, Xiaotian Zhang, Jian Li, Lin Shen
Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment. Nature communications 13 (1) (2022)
Kanglian Zheng, Xu Zhu, Shijie Fu, Guang Cao, Wen-Qing Li, Liang Xu, Hui Chen, Di Wu, Renjie Yang, Kun Wang, Wei Liu, Hong-Wei Wang, Quan Bao, Ming Liu, Chunyi Hao, Lin Shen, Baocai Xing, Xiaodong Wang
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology 303 (2) (2022)
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily M Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Changsong Qi, Jifang Gong, Jian Li, Dan Liu, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Yanshuo Cao, Xiaotian Zhang, Zhihao Lu, Ming Lu, Jiajia Yuan, Zhenghang Wang, Yakun Wang, Xiaohui Peng, Huiping Gao, Zhen Liu, Huamao Wang, Daijing Yuan, Jun Xiao, Hong Ma, Wei Wang, Zonghai Li, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results. Nature medicine 28 (6) (2022)
Mengqi Zhang, Beifang Li, Haiyan Liao, Zuhua Chen, Wenwen Huang, Jing Yang, Sai Ge, Zhongwu Li, Lin Shen, Cheng Zhang, Jing Gao
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft. Cell death discovery 8 (1) (2022)
Yanshuo Cao, Ming Lu, Yu Sun, Jifang Gong, Jie Li, Zhihao Lu, Jian Li, Xiaotian Zhang, Yan Li, Zhi Peng, Jun Zhou, Xicheng Wang, Lin Shen
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial. Journal of cancer research and clinical oncology (2022)
Yuezong Bai, Tong Xie, Zhenghang Wang, Shuang Tong, Xiaochen Zhao, Feilong Zhao, Jinping Cai, Xiaofan Wei, Zhi Peng, Lin Shen
Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer. Journal for immunotherapy of cancer 10 (3) (2022)
Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen, Zhihao Lu
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer. Cancer biology & medicine (2021)
Zhenghang Wang, Xiaochen Zhao, Chan Gao, Jifang Gong, Xicheng Wang, Jing Gao, Zhongwu Li, Jie Wang, Bo Yang, Lei Wang, Bei Zhang, Yifan Zhou, Dalei Wang, Xiaofang Li, Yuezong Bai, Jian Li, Lin Shen
Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment. Journal for immunotherapy of cancer 8 (2) (2021)
Zhihao Lu, Huan Chen, Xi Jiao, Wei Zhou, Wenbo Han, Shuang Li, Chang Liu, Jifang Gong, Jian Li, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanyan Li, Jie Li, Yan Li, Malcolm Brock, Henghui Zhang, Lin Shen
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier. Journal for immunotherapy of cancer 8 (2) (2021)
Zhihao Lu, Huan Chen, Shuang Li, Jifang Gong, Jian Li, Jianling Zou, Lihong Wu, Jianing Yu, Wenbo Han, Huaibo Sun, Xi Jiao, Xiaotian Zhang, Zhi Peng, Ming Lu, Zhenghang Wang, Henghui Zhang, Lin Shen
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Panpan Zhang, Zhongwu Li, Jie Li, Jian Li, Xiaotian Zhang, Zhihao Lu, Yu Sun, Yan Li, Jun Zhou, Xicheng Wang, Zhi Peng, Lin Shen, Ming Lu
Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm. Cancer medicine 10 (14) (2021)
Zhihao Lu, Xin Wei, Shuang Li, Chang Liu, Huan Chen, Jifang Gong, Jian Li, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yujiao Wang, Yanni Wang, Na Zhuo, Henghui Zhang, Zhihao Lu, Lin Shen
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer. NPJ precision oncology 5 (1) (2021)
Chang Liu, Yanni Wang, Shuang Li, Xi Jiao, Jianling Zou, Zhenghang Wang, Changsong Qi, Xiaotian Zhang, Jian Li, Zhihao Lu, Lin Shen
Early change in peripheral CD4+ T cells associated with clinical outcomes of immunotherapy in gastrointestinal cancer. Immunotherapy 13 (1) (2020)
Cheng Zhang, Xiaoting Lin, Qian Zhao, Yakun Wang, Fangli Jiang, Congcong Ji, Yanyan Li, Jing Gao, Jian Li, Lin Shen
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling. Journal of cancer research and clinical oncology 146 (2) (2020)
Cheng Zhang, Mengqi Zhang, Sai Ge, Wenwen Huang, Xiaoting Lin, Jing Gao, Jifang Gong, Lin Shen
Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Cancer medicine 8 (10) (2019)
Mopei Wang, Li Liang, Jiaxiong Lu, Yang Yu, Yanling Zhao, Zhenfeng Shi, Hui Li, Xin Xu, Yuxian Yan, Yan Niu, Zhentao Liu, Lin Shen, Hong Zhang
Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin-induced apoptosis. Thoracic cancer 10 (4) (2019)

Lin Shen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lin Shen